Navigation Links
Cypher Sirolimus-eluting Coronary Stent

ProductsCypher Sirolimus-eluting Coronary Stent
Company Cordis Corporation
Item Cypher Sirolimus-eluting Coronary Stent
Features Remarkable Safety
  • The CYPHER Stent has proven to be safe and effective in the largest number of drug-eluting stent clinical trials involving the most patients, over the longest period of time.
Lasting Efficacy
  • The CYPHER Stent has shown to significantly reduce late loss and target lesion revascularization (TLR), even in the most challenging trials to date.
Description The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, sirolimus elutes into the vessel wall and impedes the process of neointimal hyperplasia, thereby significantly reducing the incidence of in-stent restenosis.
Info Cordis Corporation
Customer Service: (800) 327-7714
Web site: http://www.cordis.com/

Related medicine products :

1. Cypher Stent
2. Atlantis SR Pro Coronary Imaging Catheter
3. MULTI-LINK OTW PIXEL Coronary Stent System
4. MULTI-LINK RX PIXEL Coronary Stent System
5. Express Coronary Stent System
6. S660 with Discrete Technology Coronary Stent System
7. MULTI-LINK OTW ZETA Coronary Stent System
8. MULTI-LINK OTW PENTA Coronary Stent System
9. MULTI-LINK RX PENTA Coronary Stent System
10. MULTI-LINK RX ZETA Coronary Stent System
11. MULTI-LINK OTW ULTRA Coronary Stent System
The Fathom Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design that revolutionizes access of the most tortuous vasculature....
Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
... market-leading system for laboratory accreditation management, ... the UK and Ireland managing accreditation ... pathology laboratories worldwide, including Australia, Canada, ... United States trust and rely upon ...
... The Axioskop 40 FL laboratory microscope ... and mechanical stability of research-class instruments ... microscope is ideal for routine clinical ... hematology. In addition, it has numerous ...
Medicine Products:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... patients for clear braces. People who want straight teeth without the extensive time ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... site attention and engagement over the household brands of Top-20 pharma by optimizing ... discuss how partnering with the right outsourcing payments provider can provide the technology, ...
(Date:3/27/2017)... ... ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, Vicki Mayo, was recently ... Mayo will present her pitch about the lifestyle wearable devices, Buzzies live ... ignites bold ideas by providing women access to the tools, training and networks needed ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the leading multimedia ... medicine, announces the launch of Veterinarian’s Money Digest™, a business and financial resource ... of American Veterinarian™. , “We look forward to launching Veterinarian’s Money ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... enables researchers to pursue the recent RNA methylation “gold rush” with their established ... of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  iCAD (Nasdaq: ICAD), an ... and radiation therapy for the early identification and ... Detection received Premarket Approval (PMA) from the U.S. ... is a first-of-its-kind, concurrent-read computer aided detection solution ... latest innovation available on the PowerLook® Breast Health ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... PUNE, India , March 24, 2017 Abdominal ... to reach $2,614 million by 2022, Globally, registering a CAGR of 5.1% from 2016 ... revenue, and is projected to dominate the market during the study period. ... ... Logo ...
Breaking Medicine Technology: